125 related articles for article (PubMed ID: 6362507)
1. [Bone marrow transplantation in the treatment of acute childhood leukosis].
Muñoz Villa A; Madero López L
An Esp Pediatr; 1983 Sep; 19 Suppl 19():52-5. PubMed ID: 6362507
[No Abstract] [Full Text] [Related]
2. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of graft-versus-host disease].
Wiktor-Jedrzejczak W
Acta Haematol Pol; 1987; 18(3-4):220-4. PubMed ID: 3330400
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation.
Nuscher R; Baltzer L; Repinec DA; Almquist G; Barrett JE; LaBombardi S; DeMao JD; Diver ME; Field BA; Lee MC
Am J Nurs; 1984 Jun; 84(6):764-72. PubMed ID: 6375375
[No Abstract] [Full Text] [Related]
6. Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro.
Izzi T; Polchi P; Galimberti M; Delfini C; Moretti L; Manna A; Porcellini A; Lucarelli G; Di Pietrantonj F
Haematologica; 1984; 69(2):194-210. PubMed ID: 6429005
[No Abstract] [Full Text] [Related]
7. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Hwang WY; Goh YT; Tan CH; How GF; Tan HC
Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
[TBL] [Abstract][Full Text] [Related]
8. [Acute graft-versus-host disease in allogeneic bone marrow transplantation].
Harada M; Funada H; Yoshida T; Kodo H; Mori T; Matsue K; Shiobara S; Ohtake S; Odaka K; Teshima H
Rinsho Ketsueki; 1984 Jul; 25(7):1043-51. PubMed ID: 6389930
[No Abstract] [Full Text] [Related]
9. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
10. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
[TBL] [Abstract][Full Text] [Related]
11. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
Basić-Jukić N; Labar B
Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693
[TBL] [Abstract][Full Text] [Related]
13. Current status of bone marrow transplantation.
Sullivan KM
Transplant Proc; 1989 Jun; 21(3 Suppl 1):41-50. PubMed ID: 2662535
[No Abstract] [Full Text] [Related]
14. Future directions of bone marrow transplantation.
Buskard NA
CMAJ; 1987 Aug; 137(4):277-9. PubMed ID: 3300925
[No Abstract] [Full Text] [Related]
15. [Graft-versus-host disease].
Svedentsov EP; Sharygin SL; Epifanov NS; Matveev GA
Klin Med (Mosk); 1993; 71(5):19-23. PubMed ID: 8301977
[No Abstract] [Full Text] [Related]
16. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
[TBL] [Abstract][Full Text] [Related]
17. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gluckman E; Reiffers J; Vernant JP; Jouet JP; Harrousseau JL; Fiere D; Bacigalupo A; Frassoni F; Gorin NC
Bone Marrow Transplant; 1996 Nov; 18(5):921-9. PubMed ID: 8932846
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in acute leukemia.
Beutler E; McMillan R
Blood Cells; 1982; 8(3):485-500. PubMed ID: 6760933
[TBL] [Abstract][Full Text] [Related]
20. [Outcomes of 50 leukemia patients who received bone marrow transplants from unrelated donors].
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato H; Hayakawa M; Kato C; Yamaguchi T; Kamiya Y; Yanada M; Morishima Y
Rinsho Ketsueki; 1998 Jul; 39(7):473-80. PubMed ID: 9750453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
